The role of nicotine in smoking: a dual-reinforcement model.
Models of intravenous nicotine self-administration in laboratory animals are being used to investigate the behavioral and neurobiological consequences of nicotine reinforcement, and to aid in the development of novel pharmacotherapies for smoking cessation. Central to these models is the principle of primary reinforcement, which posits that response-contingent presentation of a primary reinforcer, nicotine, engenders robust operant behavior, whereas response-independent drug delivery does not. This dictum of nicotine as a primary reinforcer has been widely used to explain why people smoke tobacco-smoking results in the rapid delivery of nicotine to the brain, setting up a cascade of neurobiological processes that strengthen subsequent smoking behavior. However, there is mounting evidence that the primary reinforcement model of nicotine self-administration fails to fully explain existing data from both the animal self-administration and human smoking literatures. We have recently proposed a "dual reinforcement" model to more fully capture the relationship between nicotine and self-administration, including smoking. Briefly, the "dual reinforcement" model posits that nicotine acts as both a primary reinforcer and a reinforcement enhancer. The latter action of nicotine had originally been uncovered by showing that a reinforcing VS, which accompanies nicotine delivery, synergizes with nicotine in the acquisition and maintenance of self-administration, and that this synergism can be reproduced by combining operant responding for the reinforcing stimulus with non-contingent (response-independent) nicotine. Thus, self-administration (and smoking) is sustained by three actions: (1) nicotine, acting as a primary reinforcer, can sustain behavior that leads to its delivery; (2) nicotine, acting as a primary reinforcer, can establish neutral environmental stimuli as conditioned reinforcers through Pavlovian associations; and (3) nicotine, acting as a reinforcement enhancer, can magnify the incentive value of accompanying stimuli, be they conditioned or unconditioned reinforcers.
Caggiula
Anthony R
AR
Department of Psychology, 3131 Sennott Square, 210 South Bouquet Street, University of Pittsburgh, Pittsburgh, PA 15260, USA. Tonypsy@pitt.edu
Donny
Eric C
EC
Palmatier
Matthew I
MI
Liu
Xiu
X
Chaudhri
Nadia
N
Sved
Alan F
AF
D000818:Animals; D001245:Association Learning; D003213:Conditioning, Psychological / Q000187:drug effects; D003463:Cues; D004195:Disease Models, Animal; D005731:Ganglionic Stimulants / Q000494:pharmacology*; D006801:Humans; D009042:Motivation; D009538:Nicotine / Q000494:pharmacology*; D051381:Rats; D012201:Reward; D012646:Self Administration; D012907:Smoking / Q000523:psychology*; D016540:Smoking Cessation / Q000523:psychology; D012931:Social Environment; D013375:Substance Withdrawal Syndrome / Q000523:psychology; D014029:Tobacco Use Disorder / Q000523:psychology*
D005731:Ganglionic Stimulants; D009538:Nicotine